Wouter Meuleman

Wouter Meuleman is an accomplished professional known for his expertise in the business and biotechnology sectors.

Wouter's educational background includes a Master of Business Administration (MBA) from the University of Cambridge, a PhD from Newcastle University, and a BSc/MSc from Ghent University. He also successfully completed his High School Diploma at Sint-Lodewijkscollege Brugge.

Throughout his career, Wouter has held key roles within various esteemed organizations. Currently, he serves as a Partner at Illumina Ventures. Prior to this, he contributed significantly as a Board Observer at Delfi Diagnostics, Board Member at Fluent BioSciences Inc., and Board Observer at Ribometrix and DNA Script.

Wouter has an extensive history with Illumina, where he served in multiple positions, including Principal, Director of Corporate and Business Development, Principal Scientist, Senior Staff Scientist, and Staff Scientist. He has also held roles at other notable companies such as Biota Technology, Desktop Genetics, Oxford Gene Technology, and Oxamer.

Before embarking on his professional journey, Wouter honed his skills as a Post-doctoral Researcher at Newcastle University and as a Project Leader at Oxford Gene Technology.

With a rich academic and professional background, Wouter Meuleman is a dynamic individual with a passion for business development and biotechnology.